Breaking: Lykos Lays Off 75% of Staff, Ropes In Pharma Veteran, Doblin Resigns Board

Finance

Reading Time: < 1 minute

Following FDA’s rejection of Lykos Therapeutics’ MDMA-assisted therapy for PTSD New Drug Application (NDA), the company has today announced a significant reorganisation. The overhaul sees around 75% of the company’s workforce laid off, with the remaining skeleton team focused on “ongoing clinical development, medical affairs, and engagement with the FDA.” As the company prepared for a…
Source

Source link

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Email
This field is for validation purposes and should be left unchanged.

Subscribe to receive the latest business and industry news in your inbox.

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Email
This field is for validation purposes and should be left unchanged.

latest from the industry

PSYCHEDELICS news

Superior Anemometers: High accuracy and robust construction

Reading Time: 2 minutes Superior Anemometers is dedicated to designing and manufacturing high-quality wind measurement devices, offering products that

September 19, 2024

Parign Hak – Grandma's Home

Reading Time: < 1 minute Parign Hak – Grandma’s Home Find someone to connect with locally. Please reach out to

September 19, 2024

Finding Your Soul’s Purpose: Harnessing Psychedelic Insights for Professional Growth

Reading Time: 2 minutes Psychedelic experiences can be a key drivers toward finding your soul’s purpose. But how can

September 19, 2024

Breaking: Lykos Lays Off 75% of Staff, Ropes In Pharma Veteran, Doblin Resigns Board

Finance

Superior Anemometers: High accuracy and robust construction

Parign Hak – Grandma's Home

Finding Your Soul’s Purpose: Harnessing Psychedelic Insights for Professional Growth

COPYRIGHT 2022 @ investly.today ALL RIGHTS RESERVED

Whitepaper